167 related articles for article (PubMed ID: 19647859)
41. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
Del Priore G; Gudipudi DK; Montemarano N; Restivo AM; Malanowska-Stega J; Arslan AA
Gynecol Oncol; 2010 Mar; 116(3):464-7. PubMed ID: 19939441
[TBL] [Abstract][Full Text] [Related]
42. Persistence and reappearance of high-risk human papillomavirus after conization.
Gosvig CF; Huusom LD; Andersen KK; Iftner A; Cederkvist L; Svare E; Iftner T; Kjaer SK
Gynecol Oncol; 2013 Dec; 131(3):661-6. PubMed ID: 24035849
[TBL] [Abstract][Full Text] [Related]
43. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
45. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
Kaufmann AM; Nieland JD; Jochmus I; Baur S; Friese K; Gabelsberger J; Gieseking F; Gissmann L; Glasschröder B; Grubert T; Hillemanns P; Höpfl R; Ikenberg H; Schwarz J; Karrasch M; Knoll A; Küppers V; Lechmann M; Lelle RJ; Meissner H; Müller RT; Pawlita M; Petry KU; Pilch H; Walek E; Schneider A
Int J Cancer; 2007 Dec; 121(12):2794-800. PubMed ID: 17721997
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
47. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
[TBL] [Abstract][Full Text] [Related]
49. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
50. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
51. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
Heymans J; Benoy IH; Poppe W; Depuydt CE
Int J Cancer; 2011 Aug; 129(4):903-9. PubMed ID: 21064091
[TBL] [Abstract][Full Text] [Related]
52. Successful photodynamic therapy with topical 5-aminolevulinic acid for five cases of cervical intraepithelial neoplasia.
Wang J; Xu J; Chen J; He Q; Xiang L; Huang X; Ding G; Xu S
Arch Gynecol Obstet; 2010 Sep; 282(3):307-12. PubMed ID: 20024569
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
Koonsaeng S; Verschraegen C; Freedman R; Bossens M; Kudelka A; Kavanagh J; Sittisomwong T; DeClercq E; Snoeck R
J Med Virol; 2001 Jun; 64(2):195-8. PubMed ID: 11360253
[TBL] [Abstract][Full Text] [Related]
54. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.
Stier EA; Goldstone SE; Einstein MH; Jay N; Berry JM; Wilkin T; Lee JY; Darragh TM; Da Costa M; Panther L; Aboulafia D; Palefsky JM
AIDS; 2013 Feb; 27(4):545-51. PubMed ID: 23032420
[TBL] [Abstract][Full Text] [Related]
55. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate.
Soergel P; Wang X; Stepp H; Hertel H; Hillemanns P
Lasers Surg Med; 2008 Nov; 40(9):611-5. PubMed ID: 18951428
[TBL] [Abstract][Full Text] [Related]
56. [Clinical study on cervical intraepithelial neoplasia with high-risk HPV infection among pregnant women].
He Y; Wu YM; Wang T; Song F; Wang Y; Zhao Q; Kong WM; Duan W; Zhu L; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):598-602. PubMed ID: 23141180
[TBL] [Abstract][Full Text] [Related]
57. Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Rahangdale L; Lippmann QK; Garcia K; Budwit D; Smith JS; van Le L
Am J Obstet Gynecol; 2014 Apr; 210(4):314.e1-314.e8. PubMed ID: 24384495
[TBL] [Abstract][Full Text] [Related]
58. A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men.
Wan J; Vittorio CC; Abuabara K; Kurd SK; Musiek A; Steinemann JM; Gelfand JM
Arch Dermatol; 2012 Feb; 148(2):257-9. PubMed ID: 22351834
[No Abstract] [Full Text] [Related]
59. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.
Keefe KA; Schell MJ; Brewer C; McHale M; Brewster W; Chapman JA; Rose GS; McMeeken DS; Lagerberg W; Peng YM; Wilczynski SP; Anton-Culver H; Meyskens FL; Berman ML
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1029-35. PubMed ID: 11588128
[TBL] [Abstract][Full Text] [Related]
60. Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
Geisler S; Speiser S; Speiser L; Heinze G; Rosenthal A; Speiser P
Obstet Gynecol; 2016 Feb; 127(2):353-9. PubMed ID: 26942365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
